Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych TopicsConsultation-liaison psychiatry

Psych · Consultation-liaison psychiatry

Palliative care psychiatry

Also known as Psychiatry in palliative care · End-of-life psychiatry · Hospice psychiatry · Terminal illness psychiatry · Palliative psychiatry

Exam-exhaustive fellowship topic on palliative care psychiatry for consultation-liaison practice — syndrome map (adjustment, demoralisation, major depression, anxiety, delirium, grief), desire for hastened death, dignity therapy and meaning-centred/CALM psychotherapy, Agar limits on antipsychotics in palliative delirium, antidepressant evidence in palliative care, early palliative care trials (Temel, Zimmermann, Bakitas), capacity and goals-of-care, family distress, and VAD-adjacent assessment. FRANZCP-primary, globally tagged.

high18 referencesUpdated 9 July 2026
On this page & tools

Your progress

Saved locally on this device.

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

New fluctuating confusion in advanced illness — treat as delirium until proven otherwise; do not start antidepressants aloneDesire for hastened death with untreated major depression, hopelessness, uncontrolled symptoms, or delirium — reassess after treating reversible driversRoutine scheduled antipsychotics for palliative delirium without non-drug care — Agar RCT showed worse symptom scores than placeboMajor treatment-limitation or VAD-adjacent decisions processed while delirious or severely affectively distorted without capacity assessmentNormalising pervasive anhedonia, worthlessness, and suicidality as 'understandable' end-of-life moodIgnoring pain, dyspnoea, constipation, retention, hypercalcaemia, or opioid toxicity as psychiatric presentationsFamily crisis and carer suicidality missed while focusing only on the index patient

Your progress

Saved locally on this device.

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

New fluctuating confusion in advanced illness — treat as delirium until proven otherwise; do not start antidepressants aloneDesire for hastened death with untreated major depression, hopelessness, uncontrolled symptoms, or delirium — reassess after treating reversible driversRoutine scheduled antipsychotics for palliative delirium without non-drug care — Agar RCT showed worse symptom scores than placeboMajor treatment-limitation or VAD-adjacent decisions processed while delirious or severely affectively distorted without capacity assessmentNormalising pervasive anhedonia, worthlessness, and suicidality as 'understandable' end-of-life moodIgnoring pain, dyspnoea, constipation, retention, hypercalcaemia, or opioid toxicity as psychiatric presentationsFamily crisis and carer suicidality missed while focusing only on the index patient

One-line fellowship answer

Palliative care psychiatry is CL psychiatry across serious illness: separate adjustment, demoralisation, major depression, anxiety, delirium, and grief; treat depression when criteria are met; reverse medical drivers of delirium and avoid routine antipsychotics (Agar); address desire for hastened death as multifactorial (depression, hopelessness, symptoms, meaning); use dignity therapy, meaning-centred work, and CALM; partner with early palliative care; and assess capacity decision-specifically without pathologising peaceful death or normalising treatable illness.[1][2][3][6][9][10]

Palliative care psychiatry is a high-yield medical psychiatry domain. Examiners test whether you can hold concurrent diagnoses (delirium plus depression), name landmark trials (Agar, Temel, Chochinov, Breitbart, Rodin), dose carefully in frail bodies, and navigate desire for hastened death without either moralising or missing treatable drivers.[2][3][6][9]

Overview and definition

Palliative care psychiatry is consultation-liaison psychiatry for people with progressive or life-limiting illness and their families — from concurrent early palliative care through terminal care and into carer bereavement. It is not limited to the last 72 hours. Psychiatry's jobs are syndrome diagnosis, risk (including desire for death), capacity and goals-of-care support, careful psychopharmacology, structured psychotherapy when feasible, and liaison with palliative medicine, nursing, psychology, social work, and spiritual care.[3][4][7]

Early palliative care (Temel; Zimmermann; Bakitas ENABLE II) frames supportive care as concurrent with disease-directed treatment, improving quality of life and mood outcomes rather than signalling abandonment of hope.[3][4][5]

Classification and syndrome map

Integrated palliative care psychiatry team supporting a patient and family with multidisciplinary care icons
Figure 1. Integrated palliative psychiatryPalliative care psychiatry integrates psychiatry, palliative medicine, psychology, nursing, and family support across mood, delirium, dignity, and goals of care.
Classification map of psychiatric syndromes in palliative care including adjustment demoralisation depression anxiety delirium and grief
Figure 2. Syndrome mapSeparate adjustment, demoralisation, major depression, anxiety, delirium, grief, and desire for hastened death — shared distress language, different actions.
SyndromeCore features near end of lifeDiscriminators
AdjustmentEmotional/behavioural symptoms tied to prognostic news, functional loss, place-of-care changeSome preserved pleasure windows; tracks stressors; less pervasive anhedonia/guilt than MDD
DemoralisationPointlessness, trapped feeling, subjective incompetence, loss of meaningMeaning collapse may dominate over classic melancholic biology; may coexist with MDD
Major depressionPervasive low mood/anhedonia, hopelessness, worthlessness, suicidal ideation for at least 2 weeksDo not rely only on fatigue/anorexia; weight affective and cognitive anchors
AnxietyWorry, panic about dying, dyspnoea-linked fear, avoidance of discussionsSeparate from hypoxia and uncontrolled symptoms; may need both medical and psychological care
DeliriumAcute fluctuating inattention and awarenessCAM-positive; often hypoactive; medical precipitants
Grief / anticipatory griefSadness, yearning, waves of emotion with preserved self-worthWaves vs pervasive anhedonia; still connected to loved ones and meaning
Desire for hastened death (DHD)Wish that death come sooner; spectrum from passive to active requestMultifactorial — not a single diagnosis; always screen depression and delirium

DSM-5-TR and ICD-11 both allow mood disorders in medical illness. Examiners care less about coding pedantry and more about not missing delirium, not under-treating MDD, and not pathologising all dying-related sadness.[1][10][13]

Epidemiology and risk

Common
Mood/anxiety/adjustment
Not rare
Desire for death
Depression + hopelessness
DHD predictors
High
Delirium near death
[1] [8] [9] [17]

Interview-based meta-analysis shows substantial prevalence of depression, anxiety, and adjustment disorder in palliative-care settings.[1] Desire for death among the terminally ill associates closely with clinical depression and can fluctuate over time.[8] In terminally ill cancer inpatients, depression and hopelessness independently predict desire for hastened death, with smaller contributions from social support and physical function.[9]

Pathophysiology and mechanisms

Mechanisms diagram of psychiatric distress in palliative illness with biological drug existential and social pathways
Figure 3. MechanismsPalliative psychiatric syndromes emerge from intersecting biological insults, drugs, existential threat, and social losses — not from a single 'terminal depression' gene.

Mechanisms are multifactorial: inflammatory signalling, organ failure, hypoxia, pain, sleep disruption, CNS disease, polypharmacy (opioids, corticosteroids, anticholinergics, benzodiazepines), and existential threat with role and dignity losses.[2][7][10]

Dignity models (Chochinov) organise suffering around illness-related concerns, dignity-conserving repertoire, and social dignity inventory — a practical scaffold for assessment and intervention beyond symptom checklists.[6][7]

Demoralisation conceptualises subjective incompetence and meaning collapse as a distinct but overlapping pathway that guides meaning-centred therapies rather than antidepressants alone.[10][11]

Clinical presentation

Tempo. Link symptoms to illness milestones: new prognostic awareness, transition off disease-modifying therapy, place-of-care change, last weeks, and imminent dying. Carer presentations often peak around transitions and after death.[3][7]

Somatic overlap. Fatigue, anorexia, and sleep change are nearly universal in advanced disease. Lean on pervasive anhedonia, hopelessness, worthlessness out of proportion, guilt, suicidal ideation, and diurnal mood variation, plus collateral functional collapse beyond medical limitation.[12][13]

Demoralisation language. "There is no point," "I am a burden," "I am trapped," with possible retained reactivity to family presence — clinically important for therapy choice.[10][11]

Delirium. Hypoactive forms are mislabelled as depression, "withdrawal," or "natural dying." Test attention; use CAM logic.[2][17]

DHD spectrum. Passive wish to die; intermittent request for hastened death; active suicidal plan; formal voluntary assisted dying (VAD) enquiry where lawful — each needs different risk intensity and documentation.[8][9]

Differential diagnosis — discriminators

  • Pervasive anhedonia/hopelessness
  • Worthlessness and guilt
  • ≥2 weeks
  • Active treatment pathway
  • May need antidepressant + therapy

  • Meaning and coping collapse
  • Tied to illness milestones
  • Some reactivity possible
  • Dignity/meaning therapies fit
  • Watch evolution into MDD

  • Acute fluctuating inattention
  • Altered awareness
  • Medical precipitants
  • Capacity often impaired
  • Fix causes; drugs secondary
[2] [10] [13] [17]

Always consider pain, dyspnoea, hypercalcaemia, hyponatraemia, hypoxia, infection, hepatic/renal failure, CNS disease, opioid toxicity, alcohol/benzodiazepine withdrawal, constipation/urinary retention, and steroid effects before locking a purely psychiatric label.[2][13][17]

Assessment

  1. Illness context: stage, prognosis communication, goals of care, recent changes, place of care.
  2. Symptom burden: pain, dyspnoea, nausea, sleep, constipation, retention.
  3. Drugs: opioids, benzodiazepines, corticosteroids, anticholinergics, recent starts/stops.
  4. Psychiatric history: prior MDD/bipolar/psychosis, self-harm, substance use.
  5. MSE: affect, anhedonia, hopelessness, psychosis, attention if any confusion.
  6. Risk: suicide and DHD (passive vs plan/intent/means); carer risk.
  7. Capacity: decision-specific for treatment limitation, place of care, and VAD-adjacent decisions where lawful.
  8. Tools: CAM when delirium possible; PHQ-9 for depression severity tracking (limitations with somatic items); dignity-related enquiry; collateral from family and palliative team.[2][8][9][17]

Desire for hastened death is a signal, not a diagnosis

DHD tracks depression, hopelessness, uncontrolled symptoms, demoralisation, and social isolation. Assess and treat reversible drivers before accepting it as a settled philosophical stance.[8][9][10]

Investigations

Directed and goal-sensitive: vitals, glucose, FBC, U&E, calcium, LFTs, infection work-up when results could change comfort or reversible confusion. Imaging only if management would change. ECG when considering QTc-risk psychotropics. Medication reconciliation is part of the investigation. Avoid investigations that only prolong suffering without altering the plan.[2][13][17]

Acute management and red flags

Do not miss reversible drivers

Agitation, "depression," or new psychosis in palliative settings may be delirium, hypercalcaemia, opioid toxicity, infection, hypoxia, constipation/retention, or steroid effects. Stabilise physiology consistent with goals of care first.[2][17]

For severe behavioural disturbance with danger (violence, line-pulling, severe distress): environmental safety, 1:1 presence, treat pain and metabolic insults, family presence if calming, and only then consider short-term low-dose antipsychotic with daily review. For alcohol/benzodiazepine withdrawal, use benzodiazepine pathways plus thiamine — not antipsychotic monotherapy.[2][17]

Active suicidality requires safety planning, means restriction, urgent psychiatry, and local mental health law only when criteria are met — statutes are jurisdiction-specific.[8][9]

Definitive management

Stepwise management algorithm for palliative care psychiatry from screening through therapies pharmacology and capacity
Figure 4. Management ladderScreen → differentiate syndromes → reverse medical causes and control symptoms → non-drug and family care → named psychotherapies → careful antidepressants → antipsychotics only for severe danger → capacity and goals of care.

Partnership with palliative medicine and early integration

Symptom control is psychiatric treatment. Uncontrolled pain, dyspnoea, and insomnia drive mood, delirium risk, and DHD. Early concurrent palliative care improved quality of life and mood in metastatic NSCLC (Temel), with broader advanced-cancer signals from Zimmermann and ENABLE II (Bakitas).[3][4][5]

Psychological therapies (name them)

Dignity therapy is a brief, individualised intervention creating a legacy document; the multicentre RCT found patients reported improved end-of-life experience and dignity-related outcomes versus standard care, even when primary distress endpoints were mixed — examiners expect the name and the model, not a claim of universal mood cure.[6][7]

Meaning-centered psychotherapy (group and individual forms) improves spiritual well-being and meaning in advanced cancer trials.[14][15]

CALM (Managing Cancer and Living Meaningfully) is a brief manualised therapy for advanced cancer that reduces depressive symptoms and prepares for end-of-life in RCT evidence.[16]

Supportive counselling, problem-solving, family meetings, and spiritual care remain foundational. Match therapy intensity to energy, prognosis, and preference.[6][14][16]

Antidepressants

Meta-analysis supports antidepressants for depression in palliative care versus placebo; European palliative cancer depression guidelines endorse structured assessment and treatment rather than therapeutic nihilism.[12][13] Cancer-specific Cochrane synthesis similarly supports antidepressant treatment with usual caveats of trial quality.[18]

Practical fellowship starts (individualise; start low in frail/older adults; check interactions and prognosis window):[12][13][18]

AgentTypical start (adult palliative)Notes
Sertraline25–50 mg oral daily; titrate toward responseOften preferred; watch nausea, hyponatraemia
Escitalopram5–10 mg oral dailySimpler kinetics; QTc caution at higher doses
Mirtazapine7.5–15 mg oral at nightSleep and appetite may help; sedation
Trial windowReassess 1–2 weeks earlyIf prognosis is days, prioritise non-drug care and symptom control

Do not withhold antidepressants solely because illness is advanced if MDD criteria are met and a meaningful trial window exists. Conversely, do not expect full response in the last days of life — goals shift to comfort and presence.[12][13]

Delirium in palliative care

Palliative delirium pathway with CAM features cause reversal non-drug care and Agar antipsychotic caution
Figure 5. Delirium pathwayUse CAM, reverse precipitants when goals allow, prioritise non-drug care, and avoid routine neuroleptics — Agar showed worse symptom scores than placebo.

Apply CAM: acute/fluctuating course + inattention + (disorganised thinking or altered consciousness).[17] Reverse infection, metabolic failure, CNS disease, constipation/retention, and deliriogenic drugs when consistent with goals.

Agar 2017: in palliative-care patients with delirium symptoms, risperidone and haloperidol produced worse symptom scores than placebo and more extrapyramidal effects. This kills the "haloperidol QID for terminal confusion" reflex. Reserve antipsychotics for severe distress or danger after non-drug measures, use the lowest effective short-term dose, and reassess daily with goals of care explicit.[2]

Example cautious short-term ranges used in CL practice for severe danger only (not scheduled default; not a substitute for local formulary): haloperidol 0.5–1 mg oral or appropriate parenteral pathway, or olanzapine 2.5–5 mg oral, with ECG/EPS monitoring where feasible, stop early.[2]

Desire for hastened death, capacity, and VAD interface

Desire for hastened death contributors and capacity assessment pillars in end-of-life care
Figure 6. DHD and capacityDHD is multifactorial. Capacity remains decision-specific: understand, retain, weigh, communicate — dying does not equal incapacity.

Screen for depression, hopelessness, demoralisation, uncontrolled symptoms, delirium, coercion, and social abandonment before framing DHD as purely autonomy-driven philosophy.[8][9][10] Treat reversible drivers and reassess. Document carefully.

Capacity is decision-specific and time-specific. Delirium and severe depression with nihilistic distortion commonly impair weighing for complex end-of-life decisions — treat, reassess in a lucid window when possible, and use substitute decision-making under local law if incapacitous. Do not invent foreign statute numbers. Where VAD is lawful, psychiatry's role is assessment of capacity, treatable mental illness, coercion, and symptom burden — not moral theatre.[2][8][9][17]

Special populations

Older adults need lower psychotropic starts, delirium vigilance, and sensory optimisation. AYA work emphasises identity, unfinished life tasks, and family systems. Non-cancer trajectories (heart failure, COPD, renal disease, MND/ALS) share DHD and demoralisation themes with longer intermittent crises. Intellectual disability requires supported decision-making and behaviour-as-pain/distress literacy. Cultural and Indigenous care needs interpreters, family-centred decision-making, and spiritual care without ethnocentric capacity shortcuts.[1][7][10]

Evidence and regional notes

ANZ / FRANZCP. CL psychiatry with palliative medicine is core liaison work. Cite Agar humility on antipsychotics, Chochinov dignity model, and demoralisation (Clarke and Kissane). VAD frameworks are jurisdiction-specific (state/territory) — know principles, not invented sections.[2][6][10]

UK / MRCPsych. NICE end-of-life and supportive care themes emphasise holistic needs assessment; CASC stations often test communication about dying, depression in medical illness, and family distress.[12][13]

US / ABPN. Early palliative care trial names (Temel, ENABLE), dignity therapy, and DHD literature are high yield; local assisted-dying laws vary by state.[3][5][6][9]

MD/DNB / NEET-SS. Expect viva on delirium vs depression, demoralisation, antidepressant use when prognosis is limited, and capacity at end of life.[2][10][12][17]

Landmark names to drop cleanly: Mitchell (prevalence), Agar (palliative delirium antipsychotics), Temel / Zimmermann / Bakitas (early palliative care), Chochinov (desire for death; dignity-conserving care; dignity therapy), Breitbart (DHD; meaning-centred psychotherapy), Rodin (CALM), Rayner/Hotopf (antidepressants and guidelines), Clarke and Kissane (demoralisation), Inouye (CAM).[1][2][3][6][8][9][10][12][16][17]

Prognosis and disposition

Depression and demoralisation can improve with integrated care even in advanced disease; early palliative care improves quality of life and mood outcomes in landmark trials.[3][4][5][12] Delirium outcomes track cause reversibility, frailty, and proximity to death — near death, delirium may be irreversible and the goal is comfort and family support.[2][17] Dignity therapy can enrich end-of-life experience even when global distress scores move modestly.[6]

Disposition plans should name joint palliative–psychiatry follow-up, crisis contacts, place-of-care preferences, family education (especially about delirium), spiritual care, and bereavement pathways for carers.[3][6][7]

Exam pearls

High-yield traps

Routine neuroleptics for palliative delirium (Agar); missing hypoactive delirium; normalising MDD as understandable; accepting DHD without screening depression/hopelessness/symptoms; processing major refusals while delirious; therapeutic nihilism about antidepressants when a trial window exists; pathologising peaceful acceptance of dying.[2][8][9][12][17]

PALLIATE (bedside scaffold)

Fellowship viva one-liners: Early palliative care is concurrent, not surrender; Agar undercuts routine neuroleptics in dying patients with delirium; DHD is a signal to treat depression, hopelessness, and symptoms; Dignity therapy and CALM are named interventions, not vague support.[2][3][6][9][16]

References

  1. [1]Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies Lancet Oncol, 2011.PMID 21251875
  2. [2]Agar MR, Lawlor PG, Quinn S, et al. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial JAMA Intern Med, 2017.PMID 27918778
  3. [3]Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer N Engl J Med, 2010.PMID 20818875
  4. [4]Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial Lancet, 2014.PMID 24559581
  5. [5]Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial JAMA, 2009.PMID 19690306
  6. [6]Chochinov HM, Kristjanson LJ, Breitbart W, et al. Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial Lancet Oncol, 2011.PMID 21741309
  7. [7]Chochinov HM Dignity-conserving care--a new model for palliative care: helping the patient feel valued JAMA, 2002.PMID 11980525
  8. [8]Chochinov HM, Wilson KG, Enns M, et al. Desire for death in the terminally ill Am J Psychiatry, 1995.PMID 7625468
  9. [9]Breitbart W, Rosenfeld B, Pessin H, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer JAMA, 2000.PMID 11147988
  10. [10]Clarke DM, Kissane DW Demoralization: its phenomenology and importance Aust N Z J Psychiatry, 2002.PMID 12406115
  11. [11]Robinson S, Kissane DW, Brooker J, et al. A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research J Pain Symptom Manage, 2015.PMID 25131888
  12. [12]Rayner L, Price A, Evans A, et al. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis Palliat Med, 2011.PMID 20935027
  13. [13]Rayner L, Price A, Hotopf M, et al. The development of evidence-based European guidelines on the management of depression in palliative cancer care Eur J Cancer, 2011.PMID 21211961
  14. [14]Breitbart W, Rosenfeld B, Pessin H, et al. Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer J Clin Oncol, 2015.PMID 25646186
  15. [15]Breitbart W, Poppito S, Rosenfeld B, et al. Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer J Clin Oncol, 2012.PMID 22370330
  16. [16]Rodin G, Lo C, Rydall A, et al. Managing Cancer and Living Meaningfully (CALM): A Randomized Controlled Trial of a Psychological Intervention for Patients With Advanced Cancer J Clin Oncol, 2018.PMID 29958037
  17. [17]Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium Ann Intern Med, 1990.PMID 2240918
  18. [18]Ostuzzi G, Matcham F, Dauchy S, et al. Antidepressants for the treatment of depression in people with cancer Cochrane Database Syst Rev, 2018.PMID 29683474